Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation

Pereira ICF, van Mechelen RJS, Wyss HM, Pinchuk L, Beckers HJM, den Toonder JMJ.

2023
Microsyst Nanoeng.

Therapeutic Area

Glaucoma
Technology

Drug Delivery

Affiliations

5600MB Eindhoven, The Netherlands Microsystems, Department of Mechanical Engineering, Eindhoven University of Technology; 5600MB Eindhoven, The Netherlands Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology; 6202AZ Maastricht, The Netherlands University Eye Clinic Maastricht, Maastricht University Medical Centre+ (MUMC+); InnFocus, Inc., a Santen Company, Miami, Florida 33186 USA; Miami, Florida 33136 USA Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.

View all Glaucoma publications